Bamrasnaradura Infectious Diseases Institute is a specialised hospital for patients infected with highly contagious diseases and used to control the outbreak of the diseases. It was found in 1960 as Bamrasnaradura Hospital.

There are 300 beds in Bamrasnaradura Infectious Disease Institute.

During the past decade, Bamrasnaradura Infectious Disease Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bamrasnaradura Infectious Disease Institute" #1 sponsor was "Janssen Research & Development, LLC" with 4 trials, followed by "Shenyang Sunshine Pharmaceutical Co., LTD." with 2 trials sponsored, "The HIV Netherlands Australia Thailand Research Collaboration" with 2 trials sponsored, "Bamrasnaradura Infectious Diseases Institute" with 1 trials sponsored and "Janssen Sciences Ireland UC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bamrasnaradura Infectious Disease Institute" #1 collaborator was "Bamrasnaradura Infectious Diseases Institute" with 2 trials as a collaborator, "Navitas Life Sciences GmbH" with 2 trials as a collaborator, "Sanpatong Hospital" with 2 trials as a collaborator, "Chiangrai Prachanukroh Hospital" with 1 trials as a collaborator and "Clinical Research Collaborative Network" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Bamrasnaradura Infectious Disease Institute" are "HIV" (3 trials), "Depression" (2 trials), "Avian Influenza" (1 trials), "CD4 Cell Counts" (1 trials) and "Human Immunodeficiency Virus Type 1" (1 trials). Many other conditions were trialed in "Bamrasnaradura Infectious Disease Institute" in a lesser frequency.

Most popular intervention types in "Bamrasnaradura Infectious Disease Institute" are "Drug" (11 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "EPIAO®" (2 trials), "EPREX®" (2 trials), "Rilematovir" (2 trials) and "Rilpivirine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bamrasnaradura Infectious Disease Institute" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Bamrasnaradura Infectious Disease Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Bamrasnaradura Infectious Disease Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bamrasnaradura Infectious Disease Institute, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".